Public Employees Benefits Program board approves phased‑in health‑insurance rate changes after heated public comment

The Public Employees Benefits Program Board voted March 19 to adopt a phased package of premium adjustments intended to address budget shortfalls and rising health‑care costs while limiting the immediate shock to employees.

The board approved a compromise that applies a three‑year phase‑in (Seagull scenario 1C) to the consumer‑driven health plan (CDHP) and the low‑deductible preferred option (LDPO), and a shorter, two‑year phase‑in (1B) for the EPO/HMO plan. The motion passed on a 4–3 vote after earlier attempts to adopt a different option failed.

The vote followed a lengthy budget presentation and an actuary briefing that identified drivers of rising costs — from specialty drugs and cancer therapies to a steep pharmacy trend tied partly to GLP‑1 medicines — and after a day of public comment by dozens of state employees, retiree advocates and union representatives who called the proposed increases unbearable.

Why this matters: The board must balance a statutory responsibility to keep the program solvent with the goal of preserving affordable benefits for roughly 17,000 participants. Seagull, the board’s actuary, recommended resetting stand‑alone rates to remove long‑running cross‑subsidies that have left some plans underpriced; the firm projected a…